Get startedLog in
    Picture of Protagenic Therapeutics logo

    PTIX — Protagenic Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Protagenic Says Submitting Appropriate Filing In Europe To Commence Phase I/Iia Trial At Major Cro Site In Germany

    Picture of Protagenic Therapeutics logoProtagenic Therapeutics
    29/06/2022 18:11
    June 29 (Reuters) - Protagenic Therapeutics Inc  PTIX.O :
    * PROTAGENIC- SUBMITTING APPROPRIATE FILING IN EUROPE TO COMMENCE PHASE I/IIA TRIAL AT MAJOR
CRO
SITE IN GERMANY, CO ANTICIPATE WILL COMMENCE IN Q3 2022
    * PROTAGENIC THERAPEUTICS INC - IS IN PROCESS OF COMPLETING REQUIREMENTS TO ANSWER
REGULATORY
QUESTIONS AND BEGIN RE-SUBMISSION PROCESS IN US

Source text - https://bit.ly/3nthIgG
Further company coverage:  PTIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Protagenic Therapeutics

    See all news